PXYN.US Praxsyn Corp

Healthcare Drug Manufacturers - Specialty & Generic USA Stocks
0.0000 USD
Close of Oct 17, 2026
Market cap
USD 6.35K
P/E
-
P/B
0.72x
ROE
107.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2015.

Is PXYN.US undervalued?

Graham number

The Graham number of Praxsyn Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Praxsyn Corp fundamental analysis

No fundamental analysis for Praxsyn Corp yet.

Praxsyn Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Praxsyn Corp

Praxsyn Corporation, a health care company, provides medical practitioners with medications and services for their patients. It formulates non-narcotic and non-habit-forming medications using therapeutic and preventative agents in the forms of transdermal creams, patches, and oral capsules for pain management, erectile dysfunction, and metabolic therapies. Praxsyn Corporation provides its products to patients covered under the California workers' compensation system, as well…

Full company profile